Management of type 2 diabetes: summary of updated NICE guidance
Year: 2008
Type: article
Abstract: The prevalence of type 2 diabetes is rising rapidly.1 More than 240 million people worldwide are estimated to have diabetes, and this number is likely to reach over 360 million by 2030.1 2 The impact on health occurs primarily through cardiovascular disease, but younger age of onset and advances in the prevention of cardiovascular disease are increasingly exposing people to the risks of microvascular damage, such as kidney and eye disease.1 The management of diabetes is complex and needs to address the prevention of cardiovascular disease and microvascular disease and the detection and management of early vascular complications.3 In recent years new evidence has accumulated on lifestyle intervention, self management through education, and self monitoring, and many new treatments have been introduced for various aspects of management. This article summarises the recommendations from an updated guideline by the National Institute for Health and Clinical Excellence (NICE) on the management of type 2 diabetes.4 NICE recommendations are based on systematic reviews of best available evidence. When minimal evidence is available, recommendations are based on the opinion of the Guideline Development Group (GDG) of what constitutes good practice. Evidence levels for the recommendations are given in italic in square brackets. ### Patient centred care
Source: BMJ
Authors: Philip Home, Jonathan Mant, Jose Diaz, Claire Turner
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W1976962580
